他泽司他在哪里买的到？

Tazerestat (trade name: Tazverik) is an EZH2 inhibitor developed by Epizyme. It was approved by the U.S. Food and Drug Administration (FDA) on January 23, 2020 for the treatment of unresectable epithelioid sarcoma in patients 16 years of age and older with metastatic or locally advanced epithelioid sarcoma.

The approval of tazetostat for epithelioid sarcoma (ES) indications is mainly based on the EZH-202 study. This study is a multi-center, open-label, single-arm phase II trial. 62 patients with locally advanced or metastatic ES with INI-1 deletion were enrolled and received tazerestat 800 mg twice daily until disease progression or intolerable toxicity. The final median follow-up time was 14 months (0.4-31 months), the disease control rate (DCR) was 26%, the overall response rate (ORR) was 15% (95%CI: 7%-26%), the complete response rate (CRR) and partial response rate (PRR) were 1.6% and 13% respectively, 67% of the patients had a duration of response (DOR) of more than 6 months, and the median overall survival (OS) was 82.4 weeks.

Where can I buy tazepam? Currently, tazerestat is not on the market in China, which means that there is no place in China where patients can buy genuine drugs. Since it is not on the market, tazerestat will not be included in the national medical insurance. Therefore, if patients want to use this drug, they can only choose to purchase the drug overseas. Although this method is effective, it is more expensive and the round trip is long and very troublesome. Therefore, many patients choose medical companion tours from domestic and overseas medical institutions to help them purchase medicines overseas. Not only are the prices affordable, but the method of purchasing medicines is also safe. Direct mail from overseas means the medicines are delivered directly to patients and are 100% authentic. However, because the price of drugs in the market changes closely with the exchange rate, it often fluctuates. For more information about tazerestat, please contact Medical Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.